Table 2.
Linear regression (β-coefficient) of annualized AVC progression stratified by age and AVC group
| Overall | Baseline AVC 1-99 | Baseline AVC ≥100 | |
|---|---|---|---|
| Per 10 years old | |||
| Unadjusted for baseline AVC | 1.43 (p=0.006) | 0.35 (p=0.002) | 1.24 (p=0.474) |
| Adjusted for baseline AVC | 0.32 (p=0.511) | 0.31 (p=0.006) | 0.44 (p=0.735) |
| Per 1 SD higher, adjusted for baseline AVC | 0.003 (p=0.511) | 0.04 (p=0.006) | 0.01 (p=0.735) |
| Age ≥65 years old | |||
| Unadjusted for baseline AVC | 26.37 (p=0.001) | 5.51 (p=0.015) | 49.65 (p=0.053) |
| Adjusted for baseline AVC | 9.67 (p=0.134) | 4.76 (p=0.034) | 46.18 (p=0.038) |
| Per 1 SD higher, adjusted for baseline AVC | 0.10 (p=0.134) | 0.05 (p=0.034) | 0.48 (p=0.038) |
All models adjusted for: sex, race/ethnicity, field center, systolic blood pressure, diastolic blood pressure, hypertension medication, total cholesterol, HDL-C, LDL-C, lipid-lowering medication, lipoprotein(a), fasting glucose, diabetes, body mass index, pack-years smoking, education, and income.